Universitätsklinikum Münster - Albert Schweitzer Campus

Münster 48149

2 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Neoplasm Metastasis, Urinary Bladder Neoplasms

Studies at this site

• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
• A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract — Recruiting now